Scala Biodesign raised $16M Series A led by Grove Ventures for ScalaOS, an AI protein design platfor...
Scala Biodesign raised $16M Series A led by Grove Ventures for ScalaOS, an AI protein design platform used by 9 of the top 20 pharma companies. 🧬 The platform combines LLMs, physics-based modeling an...